Nektar Therapeutics (NASDAQ:NKTR)
CAPS Rating:
A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.
RSS Headlines
Fool UK
Recs
Total speculation on pain kill and cancer drug.